Advisors
Caroline Popper, M.D., Senior Advisor - Regulatory Affairs
Dr. Popper is founder and President of Popper and Company, LLC, a bioscience consulting firm that guides emerging companies in the areas of commercialization strategy, technology assessment and partnering. Previously, she was Chief Business Officer at Toronto-based MDS Proteomics Inc., and held a variety of management positions during her nine-year tenure at Becton Dickinson & Co., including Vice President and General Manager, Vice President of Business Development and Strategic Planning, and Corporate Medical Director. Dr. Popper has extensive experience in diagnostics, including the development and introduction of novel diagnostic approaches. Trained as an internist and pathologist, Dr. Popper also served as an Attending Physician in the department of emergency medicine at Johns Hopkins Hospital from 1988 to 2003.
Quintiles
Quintiles Consulting's Medical Device Development practice helps the medical device companies bring products to market in the United States, Europe and the world efficiently by providing the right regulatory strategy the first time. Quintiles Consulting's team includes former FDA leaders who lend their insight to product development plans, preclinical testing, and clinical studies. Additionally, Quintiles Consulting assists in the interpretation of clinical data, the preparation of submissions, and communication and representation before regulatory bodies. Quintiles Consulting also provides advice and services in the areas of bioresearch monitoring, quality systems, validation, and pricing and reimbursement.
For more information on the Quintiles Medical Device Development Group, click here.
Sanjeev Arora, M.D., FACP, Hepatitis C Advisory Board Chairperson
Dr. Arora is Executive Vice Chairman, Department of Internal Medicine, at University of New Mexico Health Sciences Center (UNMHSC). Since 2001, he has served as Principal Investigator for more than 17 clinical trials focused on ribaviran treatment for the chronic Hepatitis C virus (HCV).
Breast Cancer Advisory Board
G. Thomas Budd, M.D., Chair
- Director, Medical Oncology Breast Cancer Program, Taussig Cancer Center
- Cleveland Clinic Foundation
- Chief Medical Officer/Medical Director, Diagnostic Service
- Clarient, Inc.
- Associate Professor of Medicine
- Yale University School of Medicine
- Associate Professor of Medicine
- UCLA Medical Division of Hematology/Oncology
- Professor of Pathology
- USC Norris Cancer Center
- Chairman, Department of Clinical Pathology
- Cleveland Clinic Foundation
- Professor of Pathology
- University of New Mexico School of Medicine